The ICaRAS randomised controlled trial: Intravenous iron to treat anaemia in people with advanced cancer - feasibility of recruitment, intervention and delivery.

Edward A DicksonOliver NgBarrie D KeelerAndrew WilcockMatthew J BrookesAustin G Acheson

Published in: Palliative medicine (2023)

The trial was feasible according to recruitment and attrition rates. Intravenous iron increased haemoglobin and may improve fatigue specific quality of life measures compared to placebo. A definitive trial is required for confirmation.

Keyphrases

study protocol
advanced cancer
phase iii
iron deficiency
randomized controlled trial
palliative care
clinical trial
high dose
phase ii
open label
squamous cell carcinoma
radiation therapy
physical activity